化学发光免疫检测技术对甲状腺肿瘤的诊断价值

The Diagnostic Value of Chemiluminescence Immunoassay Technology for Patients with Thyroid Tumor

目的:分析甲状腺肿瘤患者生化免疫检验中应用化学发光免疫检测技术的价值。方法:将2017年6月至2019年4月期间于长沙市中医医院进行治疗的疑似甲状腺肿瘤患者106例作为观察对象,对患者实施分别实施放射免疫测定技术、化学发光免疫检测技术检测,以病理检查结果作为金标准,比较两种方法的检测特异度、灵敏度、准确度进行比较,并测定患者甲状腺球蛋白水平。结果:在106例疑似甲状腺肿瘤患者中,病理检查确诊患者100例,占比94.34%。化学发光免疫检测技术的诊断准确度、特异度、灵敏度均高于放射免疫测定技术,差异具有统计学意义(P<0.05)。化学发光免疫检测技术检测的甲状腺球蛋白水平明显高于放射免疫测定技术,差异具有统计学意义(P<0.05)。结论:化学发光免疫检测技术对甲状腺肿瘤的诊断效果比放射免疫测定技术更好。

Objective To analyze the value of the application of chemiluminescence immunoassay technology in the biochemical immunoassay of patients with thyroid tumors.Methods 106 cases of suspected thyroid tumor patients who were treated in Changsha Traditional Chinese Medicine Hospital from June 2017 to April 2019 were taken as observation objects.The patients were tested by radioimmunoassay technology and chemiluminescence immunoassay technology respectively,The pathological examination results were used as the gold standard.The detection specificity,sensitivity and accuracy of two methods are compared,and the patient's thyroglobulin level is determined.Results Among 106 patients with suspected thyroid tumors,100 were diagnosed by pathological examination,accounting for 94.34%.The diagnostic accuracy,specificity,and sensitivity of chemiluminescence immunoassay technology were higher than those of radioimmunoassay technology,and the differences were statistically significant.(P<0.05),the level of thyroglobulin detected by chemiluminescence immunoassay technology was significantly higher than that by radioimmunoassay technology,and the difference was statistically significant(P<0.05).Conclusion Chemiluminescence immunoassay technology is more accurate in the diagnosis of thyroid tumors,and can provide a more effective reference for clinical and treatment.